Abstract
A series of 48 commercial benzaldehydes have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv, using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Benzaldehydes 39 and 41 exhibited a significant activity at 3.12 μg/mL. Although commercial benzaldehydes have been largely used by many research groups in search of news TB-drugs, they had not been tested previously against Mycobacterium tuberculosis. This study adds important information to the rational design of new lead anti-TB drugs.
Keywords: Antimycobacterial evaluation, Alamar Blue assay, Benzaldehydes, Cytotoxicity, Drugs, Tuberculosis, Mycobacterium tuberculosis, multidrug-resistant tuberculosis, MDR-TB, drug-resistant tuberculosis, XDR-TB, Rifampin, Isoniazid, Cell Viability Assay, RPMI 1640, DMSO, MABA, BACTEC, SAR, Mosmans's MTT
Letters in Drug Design & Discovery
Title: Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis
Volume: 7 Issue: 10
Author(s): Marcelle de Lima Ferreira, Andre Luis Peixoto Candea, Maria das Gracas Muller de Oliveira Henriques, Maria Cristina Silva Lourenco, Carlos Roland Kaiser and Marcus Vinicius Nora de Souza
Affiliation:
Keywords: Antimycobacterial evaluation, Alamar Blue assay, Benzaldehydes, Cytotoxicity, Drugs, Tuberculosis, Mycobacterium tuberculosis, multidrug-resistant tuberculosis, MDR-TB, drug-resistant tuberculosis, XDR-TB, Rifampin, Isoniazid, Cell Viability Assay, RPMI 1640, DMSO, MABA, BACTEC, SAR, Mosmans's MTT
Abstract: A series of 48 commercial benzaldehydes have been evaluated for their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv, using the Alamar Blue susceptibility test and the activity expressed as the minimum inhibitory concentration (MIC) in μg/mL. Benzaldehydes 39 and 41 exhibited a significant activity at 3.12 μg/mL. Although commercial benzaldehydes have been largely used by many research groups in search of news TB-drugs, they had not been tested previously against Mycobacterium tuberculosis. This study adds important information to the rational design of new lead anti-TB drugs.
Export Options
About this article
Cite this article as:
de Lima Ferreira Marcelle, Luis Peixoto Candea Andre, das Gracas Muller de Oliveira Henriques Maria, Cristina Silva Lourenco Maria, Roland Kaiser Carlos and Vinicius Nora de Souza Marcus, Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis, Letters in Drug Design & Discovery 2010; 7 (10) . https://dx.doi.org/10.2174/1570180811007010754
DOI https://dx.doi.org/10.2174/1570180811007010754 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multi-Target-Directed Ligands as Innovative Tools to Combat Trypanosomatid Diseases
Current Topics in Medicinal Chemistry Modulation of Cytokine Network in the Comorbidity of Schizophrenia and Tuberculosis
Current Topics in Medicinal Chemistry HIV-1 Prophylactic Vaccine Trials in Thailand
Current HIV Research Potential Benefits and Limits of Psychopharmacological Therapies in Pervasive Developmental Disorders
Current Clinical Pharmacology The Unbiased Search of Biomarkers in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Novel Synthetic Compounds as Potential Anticryptococcal Agents
Current Organic Synthesis Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production
Current Drug Targets - Inflammation & Allergy Graphical Abstracts
Letters in Organic Chemistry Renal Cell Carcinoma in a Patient with Rheumatoid Arthritis Treated with Adalimumab
Current Drug Safety Molecular Biomarkers of Disease for Diagnosis and Drug Development
Current Medicinal Chemistry A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors
Letters in Drug Design & Discovery Design, Synthesis and In Vitro Anti-Mycobacterial Activity of Chromene Fused Cytosine and Uracil Analogues
Anti-Infective Agents New Pyrrole Hydrazones Synthesized and Evaluated In Vitro as Potential Tuberculostatics
Letters in Drug Design & Discovery Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections
Current Pharmaceutical Design Synthesis of a Tetrasaccharide Present in Motif B of the Mycobacterium tuberculosis Cell Wall
Letters in Organic Chemistry Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis
Current Stem Cell Research & Therapy Phytochemical Analysis with Antioxidant and Cytotoxicity Studies of the Bioactive Principles from Zanthoxylum capense (Small Knobwood)
Anti-Cancer Agents in Medicinal Chemistry Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis
Current Topics in Medicinal Chemistry Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics